de Clercq K - Search Results

1

The history of foot-and-mouth disease virus serotype C: the first known extinct serotype?

Paton DJ, Di Nardo A, Knowles NJ, Wadsworth J, Pituco EM, Cosivi O, Rivera AM, Kassimi LB, Brocchi E, de Clercq K, Carrillo C, Maree FF, Singh RK, Vosloo W, Park MK, Sumption KJ, Ludi AB, King DP. Paton DJ, et al. Among authors: de clercq k. Virus Evol. 2021 Mar 19;7(1):veab009. doi: 10.1093/ve/veab009. eCollection 2021 Jan. Virus Evol. 2021. PMID: 35186323 Free PMC article. Review.

2

Comparative evaluation of six ELISAs for the detection of antibodies to the non-structural proteins of foot-and-mouth disease virus.

Brocchi E, Bergmann IE, Dekker A, Paton DJ, Sammin DJ, Greiner M, Grazioli S, De Simone F, Yadin H, Haas B, Bulut N, Malirat V, Neitzert E, Goris N, Parida S, Sørensen K, De Clercq K. Brocchi E, et al. Among authors: de simone f, de clercq k. Vaccine. 2006 Nov 17;24(47-48):6966-79. doi: 10.1016/j.vaccine.2006.04.050. Epub 2006 May 6. Vaccine. 2006. PMID: 16753241

3

Foot-and-mouth disease virus: a first inter-laboratory comparison trial to evaluate virus isolation and RT-PCR detection methods.

Ferris NP, King DP, Reid SM, Hutchings GH, Shaw AE, Paton DJ, Goris N, Haas B, Hoffmann B, Brocchi E, Bugnetti M, Dekker A, De Clercq K. Ferris NP, et al. Among authors: de clercq k. Vet Microbiol. 2006 Oct 31;117(2-4):130-40. doi: 10.1016/j.vetmic.2006.06.001. Epub 2006 Jul 17. Vet Microbiol. 2006. PMID: 16846700

4

Application of non-structural protein antibody tests in substantiating freedom from foot-and-mouth disease virus infection after emergency vaccination of cattle.

Paton DJ, de Clercq K, Greiner M, Dekker A, Brocchi E, Bergmann I, Sammin DJ, Gubbins S, Parida S. Paton DJ, et al. Among authors: de clercq k. Vaccine. 2006 Oct 30;24(42-43):6503-12. doi: 10.1016/j.vaccine.2006.06.032. Epub 2006 Jul 5. Vaccine. 2006. PMID: 16872727 Review.

5

Foot-and-mouth disease non-structural protein serology in cattle: use of a Bayesian framework to estimate diagnostic sensitivity and specificity of six ELISA tests and true prevalence in the field.

Goris N, Praet N, Sammin D, Yadin H, Paton D, Brocchi E, Berkvens D, De Clercq K. Goris N, et al. Among authors: de clercq k. Vaccine. 2007 Oct 10;25(41):7177-96. doi: 10.1016/j.vaccine.2007.07.023. Epub 2007 Aug 2. Vaccine. 2007. PMID: 17709157

6

Use of continuous results to compare ELISAs for the detection of antibodies to non-structural proteins of foot-and-mouth disease virus.

Dekker A, Sammin D, Greiner M, Bergmann I, Paton D, Grazioli S, de Clercq K, Brocchi E. Dekker A, et al. Among authors: de clercq k. Vaccine. 2008 May 23;26(22):2723-32. doi: 10.1016/j.vaccine.2008.03.052. Epub 2008 Apr 11. Vaccine. 2008. PMID: 18450336

7

The use of serosurveys following emergency vaccination, to recover the status of "foot-and-mouth disease free where vaccination is not practised".

Paton DJ, Füssel AE, Vosloo W, Dekker A, De Clercq K. Paton DJ, et al. Among authors: de clercq k. Vaccine. 2014 Dec 12;32(52):7050-6. doi: 10.1016/j.vaccine.2014.10.064. Epub 2014 Nov 5. Vaccine. 2014. PMID: 25444827 Free article. Review.

8

A thiazepino[4,5-a]benzimidazole derivative hampers the RNA replication of Eurasian serotypes of foot-and-mouth disease virus.

Lefebvre DJ, De Vleeschauwer AR, Goris N, Van Borm S, Chimirri A, Monforte AM, Valdazo-Gonzalez B, King DP, Neyts J, De Clercq K. Lefebvre DJ, et al. Among authors: de vleeschauwer ar, de clercq k. Biochem Biophys Res Commun. 2014 Dec 12;455(3-4):378-81. doi: 10.1016/j.bbrc.2014.11.023. Epub 2014 Nov 15. Biochem Biophys Res Commun. 2014. PMID: 25446115

9

Outbreak investigations and molecular characterization of foot-and-mouth disease viruses circulating in south-west Niger.

Souley Kouato B, Elliot FM, King DP, Hyera J, Knowles NJ, Ludi AB, Mioulet V, Matlho G, De Clercq K, Thys E, Marichatou H, Issa S, Saegerman C. Souley Kouato B, et al. Among authors: de clercq k. Transbound Emerg Dis. 2018 Feb;65(1):146-157. doi: 10.1111/tbed.12642. Epub 2017 Mar 27. Transbound Emerg Dis. 2018. PMID: 28345819 Free article.

10

Development and validation of a foot-and-mouth disease virus SAT serotype-specific 3ABC assay to differentiate infected from vaccinated animals.

Chitray M, Grazioli S, Willems T, Tshabalala T, De Vleeschauwer A, Esterhuysen JJ, Brocchi E, De Clercq K, Maree FF. Chitray M, et al. Among authors: de vleeschauwer a, de clercq k. J Virol Methods. 2018 May;255:44-51. doi: 10.1016/j.jviromet.2018.02.006. Epub 2018 Feb 8. J Virol Methods. 2018. PMID: 29428400

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

204 results

Search Page